| 2026-09-24 | Trial | New trial registered: Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face Attention | Trial register ClinicalTrials.gov |
| 2026-09-09 | Recall | FDA recall, Class II: Baxter Healthcare Corporation. CGMP Deviations | Regulator FDA enforcement reports |
| 2026-09-09 | Recall | FDA recall, Class II: Baxter Healthcare Corporation. CGMP Deviations | Regulator FDA enforcement reports |
| 2026-08-20 | Trial | New trial registered: Bedtime Device Restriction and Desmopressin in PMNE. | Trial register ClinicalTrials.gov |
| 2026-08-17 | Label | FDA label revised: VASOPRESSIN (ANDA213988) | Regulator FDA drug label register |
| 2026-08-05 | Trial | New trial registered: Terlipressin vs Placebo to Reduce Bleeding in Fibroid Surgery | Trial register ClinicalTrials.gov |
| 2026-07-22 | Trial | New trial registered: Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Pros | Trial register ClinicalTrials.gov |
| 2026-07-21 | Label | FDA label revised: VASOPRESSIN (NDA212593) | Regulator FDA drug label register |
| 2026-07-17 | Trial | New trial registered: Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors | Trial register ClinicalTrials.gov |
| 2026-07-13 | Trial | New trial registered: Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic Shock | Trial register ClinicalTrials.gov |
| 2026-07-10 | Label | FDA label revised: VASOPRESSIN (NDA212593) | Regulator FDA drug label register |
| 2026-07-06 | Federal Register | Federal Register notice: Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn F | Regulator Federal Register |
| 2026-07-02 | Results | Results posted: Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock | Trial register ClinicalTrials.gov |
| 2026-06-26 | Trial | New trial registered: Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V) | Trial register ClinicalTrials.gov |
| 2026-06-24 | Recall | FDA recall, Class II: IntegraDose Compounding Services LLC. Subpotent Drug | Regulator FDA enforcement reports |
| 2026-06-03 | Federal Register | Federal Register notice: Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications | Regulator Federal Register |
| 2026-05-29 | Trial | New trial registered: Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery, | Trial register ClinicalTrials.gov |
| 2026-05-05 | Trial | New trial registered: Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease | Trial register ClinicalTrials.gov |
| 2026-05-05 | Trial | New trial registered: Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance | Trial register ClinicalTrials.gov |
| 2026-05-04 | Trial | New trial registered: International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination | Trial register ClinicalTrials.gov |
| 2026-04-29 | Results | Results posted: Vasopressin in Intraabdominal Pressure Elevation | Trial register ClinicalTrials.gov |
| 2026-04-21 | Label | FDA label revised: Vasostrict (NDA204485) | Regulator FDA drug label register |
| 2026-04-16 | Label | FDA label revised: Vasostrict (NDA204485) | Regulator FDA drug label register |
| 2026-03-27 | Trial | New trial registered: Phenotype Guided Vasoactive Medication During Kidney Transplantation | Trial register ClinicalTrials.gov |
| 2026-03-10 | Trial | New trial registered: Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome | Trial register ClinicalTrials.gov |
| 2026-03-03 | Trial | New trial registered: Vasopressin vs. Uterine Artery Clamping for Laparoscopic Cesarean Scar Niche Repair | Trial register ClinicalTrials.gov |
| 2026-02-20 | Trial | New trial registered: Tranexamic Acid vs Vasopressin in Placenta Previa Trial | Trial register ClinicalTrials.gov |
| 2026-02-11 | Trial | New trial registered: Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation | Trial register ClinicalTrials.gov |
| 2026-01-07 | Trial | New trial registered: Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome | Trial register ClinicalTrials.gov |
| 2025-12-26 | Trial | New trial registered: Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation | Trial register ClinicalTrials.gov |
| 2025-12-18 | Label | FDA label revised: VASOPRESSIN (ANDA214314) | Regulator FDA drug label register |
| 2025-12-18 | Trial | New trial registered: Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency | Trial register ClinicalTrials.gov |
| 2025-12-10 | Trial | New trial registered: Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology | Trial register ClinicalTrials.gov |
| 2025-12-01 | Trial | New trial registered: Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication | Trial register ClinicalTrials.gov |
| 2025-11-26 | Trial | New trial registered: Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction | Trial register ClinicalTrials.gov |
| 2025-10-24 | Label | FDA label revised: VASOPRESSIN (ANDA214314) | Regulator FDA drug label register |
| 2025-09-30 | Trial | New trial registered: Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE | Trial register ClinicalTrials.gov |
| 2025-09-19 | Results | Results posted: Intranasal Vasopressin Treatment in Children With Autism | Trial register ClinicalTrials.gov |
| 2025-08-26 | Label | FDA label revised: Vasopressin (ANDA216963) | Regulator FDA drug label register |
| 2025-08-04 | Trial | New trial registered: Intracervical Vasopressin | Trial register ClinicalTrials.gov |
| 2025-07-29 | Results | Results posted: Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy | Trial register ClinicalTrials.gov |
| 2025-07-16 | Trial | New trial registered: Weaning Approaches for Vasopressin in Sepsis | Trial register ClinicalTrials.gov |
| 2025-07-11 | Label | FDA label revised: VASOPRESSIN (ANDA214314) | Regulator FDA drug label register |
| 2025-07-04 | Trial | New trial registered: Systematic Adjunction of Vasopressine in Septic Shock | Trial register ClinicalTrials.gov |
| 2025-07-03 | Trial | New trial registered: Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock | Trial register ClinicalTrials.gov |
| 2025-06-17 | Label | FDA label revised: Vasopressin in 0.9% Sodium Chloride (NDA217766) | Regulator FDA drug label register |
| 2025-06-17 | Trial | New trial registered: Sleep Disorders in Hypothalamic and Pituitary Damage | Trial register ClinicalTrials.gov |
| 2025-05-15 | Label | FDA label revised: vasopressin (ANDA213988) | Regulator FDA drug label register |
| 2025-05-01 | Trial | New trial registered: Vasopressin Use in Septic Shock From Türkiye | Trial register ClinicalTrials.gov |
| 2025-04-18 | Trial | New trial registered: Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery | Trial register ClinicalTrials.gov |
| 2025-04-16 | Trial | New trial registered: Vasopressin in the Elderly: Physiological Changes in Neuroendocrine Function and Urinary Secretion in Healthy Aging | Trial register ClinicalTrials.gov |
| 2025-03-04 | Trial | New trial registered: Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation | Trial register ClinicalTrials.gov |
| 2025-03-01 | Label | FDA label revised: Vasopressin (NDA212593) | Regulator FDA drug label register |
| 2025-02-27 | Label | FDA label revised: VASOPRESSIN (ANDA213206) | Regulator FDA drug label register |
| 2025-02-21 | Label | FDA label revised: Vasopressin in 0.9% Sodium Chloride (NDA217569) | Regulator FDA drug label register |
| 2025-02-15 | Label | FDA label revised: VASOPRESSIN (ANDA213206) | Regulator FDA drug label register |
| 2025-02-05 | Trial | New trial registered: Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls | Trial register ClinicalTrials.gov |
| 2025-01-31 | Trial | New trial registered: Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock | Trial register ClinicalTrials.gov |
| 2025-01-30 | Trial | New trial registered: Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis | Trial register ClinicalTrials.gov |
| 2025-01-23 | Trial | New trial registered: Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls | Trial register ClinicalTrials.gov |
| 2025-01-13 | Trial | New trial registered: Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis | Trial register ClinicalTrials.gov |
| 2025-01-13 | Trial | New trial registered: Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis | Trial register ClinicalTrials.gov |
| 2025-01-09 | Results | Results posted: Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients: | Trial register ClinicalTrials.gov |
| 2024-11-29 | Trial | New trial registered: Early Versus Late Adjunctive Vasopressin in Septic Shock | Trial register ClinicalTrials.gov |
| 2024-11-09 | Label | FDA label revised: Vasopressin (ANDA216963) | Regulator FDA drug label register |
| 2024-11-06 | Trial | New trial registered: Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insi | Trial register ClinicalTrials.gov |
| 2024-10-31 | Label | FDA label revised: Vasopressin (NDA212593) | Regulator FDA drug label register |
| 2024-10-10 | Trial | New trial registered: Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome | Trial register ClinicalTrials.gov |
| 2024-10-09 | Results | Results posted: Use of Vasopressin Following the Fontan Operation | Trial register ClinicalTrials.gov |
| 2024-10-09 | Results | Results posted: Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE) | Trial register ClinicalTrials.gov |
| 2024-10-02 | Trial | New trial registered: Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies | Trial register ClinicalTrials.gov |
| 2024-09-20 | Trial | New trial registered: The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling | Trial register ClinicalTrials.gov |
| 2024-08-16 | Trial | New trial registered: Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Inj | Trial register ClinicalTrials.gov |
| 2024-08-09 | Trial | New trial registered: Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU | Trial register ClinicalTrials.gov |
| 2024-07-31 | Label | FDA label revised: vasopressin (ANDA213988) | Regulator FDA drug label register |
| 2024-07-26 | Trial | New trial registered: Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study) | Trial register ClinicalTrials.gov |
| 2024-07-12 | Trial | New trial registered: Norepinephrine Equivalent Dose of Vasopressin, Phenylephrine and Epinephrine in Septic Shock | Trial register ClinicalTrials.gov |
| 2024-07-09 | Trial | New trial registered: Mifepristone vs Misoprostol | Trial register ClinicalTrials.gov |
| 2024-07-07 | Label | FDA label revised: vasopressin (ANDA212944) | Regulator FDA drug label register |
| 2024-07-05 | Trial | New trial registered: Saline Infusion Test in Hyponatremia | Trial register ClinicalTrials.gov |
| 2024-06-24 | Trial | New trial registered: Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock | Trial register ClinicalTrials.gov |
| 2024-06-18 | Trial | New trial registered: Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis | Trial register ClinicalTrials.gov |
| 2024-06-14 | Trial | New trial registered: Identifying Oxytocin Deficiency in Adults With Pituitary Disease | Trial register ClinicalTrials.gov |
| 2024-05-29 | Recall | FDA recall, Class II: American Regent, Inc.. Subpotent product in addition to having out-of-specification results for impurities. | Regulator FDA enforcement reports |
| 2024-05-23 | Trial | New trial registered: Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator | Trial register ClinicalTrials.gov |
| 2024-05-22 | Trial | New trial registered: Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis | Trial register ClinicalTrials.gov |
| 2024-05-21 | Trial | New trial registered: Registry of Patients in Shock Treated With Vasopressin | Trial register ClinicalTrials.gov |
| 2024-05-17 | Trial | New trial registered: Tranexamic Acid in Vaginal Reconstructive Surgery | Trial register ClinicalTrials.gov |
| 2024-05-07 | Results | Results posted: Desmopressin for Bedwetting in Children With SCD | Trial register ClinicalTrials.gov |
| 2024-04-08 | Trial | New trial registered: Descriptive Observational Study of Patient-performed Pre-oxygenation | Trial register ClinicalTrials.gov |
| 2024-04-03 | Trial | New trial registered: Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial) | Trial register ClinicalTrials.gov |
| 2024-04-01 | Trial | New trial registered: Shock and Acute Conditions OutcOmes Platform | Trial register ClinicalTrials.gov |
| 2024-03-29 | Trial | New trial registered: Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial | Trial register ClinicalTrials.gov |
| 2024-03-27 | Trial | New trial registered: Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma | Trial register ClinicalTrials.gov |
| 2024-03-25 | Trial | New trial registered: The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study | Trial register ClinicalTrials.gov |
| 2024-03-25 | Trial | New trial registered: Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study | Trial register ClinicalTrials.gov |
| 2024-03-18 | Results | Results posted: A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers | Trial register ClinicalTrials.gov |
| 2024-03-12 | Trial | New trial registered: Dexmedetomidine and Vasopressin in Septic Shock | Trial register ClinicalTrials.gov |
| 2024-03-04 | Trial | New trial registered: Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy | Trial register ClinicalTrials.gov |
| 2024-02-29 | Trial | New trial registered: Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis | Trial register ClinicalTrials.gov |